$1.85 Billion is the total value of Chicago Partners Investment Group LLC's 657 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | DIMENSIONAL ETF TRUSTultrashort fixed | $7,174,814 | – | 142,825 | +100.0% | 0.39% | – | |
CBOE | New | CBOE GLOBAL MKTS INC | $1,035,987 | – | 6,426 | +100.0% | 0.06% | – |
INDA | New | ISHARES TRmsci india etf | $801,333 | – | 18,371 | +100.0% | 0.04% | – |
New | ZURN ELKAY WATER SOLNS CORP | $757,741 | – | 29,727 | +100.0% | 0.04% | – | |
ITT | New | ITT INC | $626,208 | – | 6,701 | +100.0% | 0.03% | – |
New | MATTHEWS ASIA FDSemerging markets | $617,932 | – | 24,885 | +100.0% | 0.03% | – | |
VGIT | New | VANGUARD SCOTTSDALE FDSinter term treas | $508,788 | – | 8,994 | +100.0% | 0.03% | – |
LEGN | New | LEGEND BIOTECH CORPsponsored ads | $322,700 | – | 4,935 | +100.0% | 0.02% | – |
ESGV | New | VANGUARD WORLD FDesg us stk etf | $301,867 | – | 4,091 | +100.0% | 0.02% | – |
VNLA | New | JANUS DETROIT STR TRhendrsn shrt etf | $250,648 | – | 5,230 | +100.0% | 0.01% | – |
TSHA | New | TAYSHA GENE THERAPIES INC | $242,222 | – | 111,111 | +100.0% | 0.01% | – |
VIOV | New | VANGUARD ADMIRAL FDS INCsmlcp 600 val | $240,526 | – | 3,331 | +100.0% | 0.01% | – |
VFVA | New | VANGUARD WELLINGTON FDus value factr | $233,958 | – | 2,454 | +100.0% | 0.01% | – |
TPL | New | TEXAS PACIFIC LAND CORPORATI | $246,893 | – | 133 | +100.0% | 0.01% | – |
New | FIRST TR EXCHNG TRADED FD VIcboe vest us equ | $235,796 | – | 7,873 | +100.0% | 0.01% | – | |
NOC | New | NORTHROP GRUMMAN CORP | $221,214 | – | 460 | +100.0% | 0.01% | – |
New | FIRST TR EXCHNG TRADED FD VIft cboe vest u s | $220,967 | – | 7,450 | +100.0% | 0.01% | – | |
PSQ | New | PROSHARES TRshort qqq new | $220,200 | – | 20,000 | +100.0% | 0.01% | – |
New | TKO GROUP HOLDINGS INCcl a | $231,513 | – | 2,936 | +100.0% | 0.01% | – | |
ANTM | New | ELEVANCE HEALTH INC | $219,631 | – | 486 | +100.0% | 0.01% | – |
EPAM | New | EPAM SYS INC | $206,989 | – | 931 | +100.0% | 0.01% | – |
CEF | New | SPROTT PHYSICAL GOLD & SILVEtr unit | $208,377 | – | 11,331 | +100.0% | 0.01% | – |
FV | New | FIRST TR EXCHANGE-TRADED FDdorsey wrt 5 etf | $201,977 | – | 4,761 | +100.0% | 0.01% | – |
CEQP | New | CRESTWOOD EQUITY PARTNERS LPunit ltd partner | $203,013 | – | 7,258 | +100.0% | 0.01% | – |
MRVL | New | MARVELL TECHNOLOGY INC | $212,750 | – | 4,340 | +100.0% | 0.01% | – |
New | VERALTO CORP | $209,638 | – | 2,916 | +100.0% | 0.01% | – | |
CVAC | New | CUREVAC N V | $59,377 | – | 10,855 | +100.0% | 0.00% | – |
ABOS | New | ACUMEN PHARMACEUTICALS INC | $44,946 | – | 13,579 | +100.0% | 0.00% | – |
ESPR | New | ESPERION THERAPEUTICS INC NE | $23,464 | – | 29,499 | +100.0% | 0.00% | – |
CLOV | New | CLOVER HEALTH INVESTMENTS CO | $15,693 | – | 17,000 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-10-26
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Enterprise Products Partners LP | 36 | Q3 2023 | 5.9% |
ISHARES TR | 36 | Q3 2023 | 5.2% |
BERKSHIRE HATHAWAY INC DEL | 36 | Q3 2023 | 4.8% |
Vanguard S&P 500 ETF | 36 | Q3 2023 | 4.2% |
ISHARES TR | 36 | Q3 2023 | 4.5% |
KINDER MORGAN INC DEL | 36 | Q3 2023 | 8.1% |
VANGUARD INDEX FDS | 36 | Q3 2023 | 3.0% |
Vanguard Mid-Cap ETF | 36 | Q3 2023 | 3.2% |
SPDR S&P MIDCAP 400 ETF TR | 36 | Q3 2023 | 3.1% |
ENERGY TRANSFER LP | 36 | Q3 2023 | 3.1% |
View Chicago Partners Investment Group LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-25 |
13F-HR | 2024-02-23 |
13F-HR | 2023-10-26 |
13F-HR | 2023-08-08 |
13F-HR | 2023-04-26 |
13F-HR | 2023-02-09 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-04 |
13F-HR | 2022-05-20 |
13F-HR | 2022-02-15 |
View Chicago Partners Investment Group LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.